Pharmadule receives an order from Sicor Biotech UAB in Lithuania for a complete Biotech Production Facility

Pharmadule AB, the world leader in high-tech modular facilities for the pharmaceutical and biopharmaceutical industries, has signed a contract with Sicor Biotech UAB in Vilnius, Lithuania for the delivery of a modular production facility. Pharmadule’s scope comprises design, fabrication, installation and validation of a complete Biotech Production Facility. Pharmadule’s modular concept allows 80% of the construction to be completed in Pharmadule’s workshop resulting in a very high and predictable quality, a short delivery schedule and financial benefits for the customers. The facility will be delivered to Sicor Biotech’s site for installation, qualification and hand over to the client by January, 2011. It will be delivered according to European Union and US quality standards, and is the second complete Biotech Facility delivered by Pharmadule to Sicor Biotech. For more information, please contact: Matts Lindqvist, Executive Vice President, Commercial Director, Pharmadule Tel: + 08 587 42 744 E-mail: matts.lindqvist@pharmadule.com